Immunic Press Release
2021-12-10

Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer

NEW YORK, Dec. 9, 2021…
read more
ONA Press Release
2021-12-02

ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors

ONA Therapeutics Appoints Dr Michel…
read more
Confo Therapeutics Press Release
2021-11-30

Confo Therapeutics Enters Collaborative Agreement with Regeneron

Confo Therapeutics Enters Collaborative Agreement…
read more
Immunic Press Release
2021-11-22

Immunic, Inc. Announces Enrollment of First Patient in its Phase 3 ENSURE Program of vidofludimus calcium (IMU-838) in Relapsing Multiple Sclerosis

NEW YORK, Nov. 18, 2021…
read more
Immunic Press Release
2021-11-04

Immunic, Inc. Reports Third Quarter 2021 Financial Results and Highlights Recent Activity

– Fully Enrolled Phase 2…
read more
Minoryx Press Release
2021-11-03

Additional data from Minoryx’s Phase 2/3 ADVANCE clinical trial presented at American Neurological Association (ANA) 2021

Presentation highlights reduction in cerebral…
read more
Novadip Press Release
2021-10-28

Novadip Biosciences announces EUR 19 million Series B financing backed by international investors

Novadip Biosciences announces EUR 19…
read more
Immunic Press Release
2021-10-28

Immunic, Inc. Announces Completion of Enrollment of its Phase 2 CALDOSE-1 Trial of IMU-838 in Moderate-to-Severe Ulcerative Colitis

  – Top-Line Data Expected…
read more
Egle Therapeutics Press Release
2021-10-22

Egle Therapeutics raises 40 million € Series A to develop First-In-Class T-regulatory cells therapies based on Treg-starvers

Egle Therapeutics SAS (Egle), an…
read more
ONA Press Release
2021-10-21

ONA Therapeutics Strengthens Scientific Leadership Team

ONA Therapeutics Strengthens Scientific Leadership…
read more